MariMed Announces Agreement to Acquire Kind Therapeutics USA, LLC, A Maryland Licensed Vertically Integrated Cannabis… Jan 5, 2022
Awakn Life Sciences Expands World’s First Ketamine Study Beyond Gambling Disorder to Include Additional Behavioral… Jan 5, 2022
InMed Issues Annual Letter to Shareholders Highlighting Key Accomplishments from 2021 and Providing 2022 Outlook Jan 5, 2022
The McQuade Center for Strategic Research and Development and Mindset Pharma Collaborate to Develop Psychedelic… Jan 5, 2022
Awakn Life Sciences Announces Voluntary Lock-up Agreement Extension with Management, Board of Directors and Key… Jan 4, 2022
